US suspends chikungunya vaccine Ixchiq over 'serious' side effects: Valneva
US health authorities have suspended the license for the Ixchiq vaccine against the chikungunya virus following reports of "serious adverse events," the drug's French maker said Monday.
Aug 25, 2025
0
38








